The FDA Story, And Why Its Timely Again The regulatory picture is the reason this topic keeps resurfacing
Not all patients are eligible for GLP-1s
TL;DR: In a large sample of US Veterans, GLP-1 drugs were associated with reduced risk of substance use and psychotic disorders, seizures, neurocognitive disorders (including Alzheimers disease and dementia), coagulation disorders, cardiometabolic disorders, infectious illnesses and several respiratory conditions, but increased risk of gastrointestinal issues, hypotension (low blood pressure), and some kidney-related conditions
Energize Skin CellsMethylene blue fuels mitochondrial energy at the cellular level
Reviewing the mechanism of actionspecifically how it influences hunger, fullness, satisfaction, and food cravingscan help patients understand that weight loss results from a medication-induced calorie deficit, not from burning fat or boosting metabolism